Skip to main content

Advertisement

Table 2 Comparison of cost and clinical outcome measures between groups that were included in the economic evaluation

From: Cost-effectiveness of using a motion-sensor biofeedback treatment approach for the management of sub-acute or chronic low back pain: economic evaluation alongside a randomised trial

  Intervention Control Regression coeff (robust 95% CI)
$AUD lost productivity (total over 12 months) $-6081 ($19, 627), $-958 ($20,364) $-5123 ($-10,174, $-72)
$AUD increase in medication use (total over 12 months) $81 ($170) $166 ($293) $-85 ($-238, $68)
$AUD absolute imaging use $52 ($191) $66 ($169) $-14 ($-125, $97)
$AUD absolute non-trial medical & therapies use $137 ($232) $170 ($285) $-53 ($-105, $-0)
$AUD absolute trial medical & therapies use $993 ($217) $516 ($71) $477 ($447, $508)
$AUD total cost (primary analysis) $-4822 ($19,667) $-40 ($20,278) $-4781 ($-9748, $186)
$AUD total cost (sensitivity analysis) $-4822 ($19,667) $-557 ($20,277) $-4265 ($-9221, $691)
Patient Global Impression of Change 8 Very much improved 2 Very much improved  
15 Much improved 7 Much improved
10 Minimally improved 3 Minimally improved
5 No change 21 No change
0 Minimally worse 10 Minimally worse
0 Much worse 1 Much worse
0 Very much worse 1 Very much worse
n (%) very or much improved on Patient Global Impression of Change (primary analysis) 23 (61%) 9 (20%) 0.41 (0.27, 0.54)
n (%) very or much or minimally improved on Patient Global Impression of Change (sensitivity analysis) 33 (87%) 12 (26%) 0.60 (0.46, 0.74)
  1. Data are mean (sd)